Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion type Assertion NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_head.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion description "[However, only a subset of patients responds to this therapy, most probably due to loss of vitamin D receptor (VDR) expression during tumour progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_provenance.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion evidence source_evidence_literature NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_provenance.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion SIO_000772 15770204 NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_provenance.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion wasDerivedFrom befree-20140225 NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_provenance.
- NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_assertion wasGeneratedBy ECO_0000203 NP875779.RAZle9goqFtwLISdHrMtltYTsRaB_IaAp5dts8R9kfEAo130_provenance.